Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
gptkb:170729-80-3
|
| gptkbp:developer |
gptkb:Merck_&_Co.
|
| gptkbp:drugClass |
recombinant human growth hormone
ghrelin receptor agonist |
| gptkbp:hasClinicalTrialStatus |
investigational
|
| gptkbp:hasInChIKey |
QZJTYWYYNRTZJC-IBGZPJMESA-N
|
| gptkbp:hasMolecularFormula |
C27H36N4O5
|
| gptkbp:hasSMILES |
CC(Cc1ccc2OCOc2c1)NC(=O)CCCN3C=CN=C3N
|
| gptkbp:hasTherapeuticUse |
treatment of growth hormone deficiency
treatment of obesity treatment of muscle wasting |
| gptkbp:hasUNII |
QX8X9C6UFZ
|
| https://www.w3.org/2000/01/rdf-schema#label |
170729-80-3
|
| gptkbp:IUPACName |
2-amino-N-[(2R)-1-(1,3-benzodioxol-5-yl)propan-2-yl]-4-(1H-imidazol-4-yl)butanamide
|
| gptkbp:legalStatus |
investigational
|
| gptkbp:molecularWeight |
528.6 g/mol
|
| gptkbp:name |
gptkb:MK-677
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL121412
159633 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
gptkb:Ibutamoren
|
| gptkbp:bfsParent |
gptkb:Emend
|
| gptkbp:bfsLayer |
5
|